shown that exogenous surfactant is more uniformly distributed if given at birth before ventilation or if followed by high-frequency ventilation (HFV) after establishing conventional ventilation (CV). We hypothesized that the preterm rabbit pup would respond similarly and that improved respiratory system compliance (Crs) would accompany improved surfactant distribution. We randomized pups (27 d gestation) into three groups: control, surfactant at birth, and surfactant after 15 rnin of CV (rescue). We administered dipalmitoylphosphatidyl-[3H]choline-labe1ed natural surfactant by tracheostomy to each of the treated groups. The two treatment groups were treated for 15 rnin with either HFV or CV and subsequently with CV. We measured Crs at 15, 25,35, and 45 min after surfactant. Lungs from pups treated with CV or HFV (n = 89) for 15 min, with and without 30 rnin of subsequent (JV, were cut into 32 pieces that were counted for distribution of label or were sectioned for quantitative morphometry (n = 36).
The surfactant in mature lungs with normal function is probably uniformly distributed, inasmuch as it is synthesized and secreted by type I1 cells distributed throughout the terminal bronchioles and alveoli. Immature lungs with abnormal function have a uniform radiographic appearance of hypoaeration and a uniform distribution of epithelial cell changes and hyaline membranes on histologic examination. Treatment of premature animals and human infants with exogenous surfactant improves lung function (1). For exogenous surfactant to be optimally effective in improving lung function, it must be both efficacious ' and uniformly distributed in the lungs (2).
Jobe et al. (3) gave natural sheep surfactant to lambs before the first breath and demonstrated a greater improvement in gas exchange and lung compliance than when it was given after 0.5 h of mechanical ventilation. Surfactant was also more uniformly distributed when given before ventilation. The authors speculated that this was because the surfactant mixed uniformly with the fetal lung liquid that was being absorbed into the alveoli (3).
Walther et al. (4) , demonstrated that exogenous surfactant was distributed more uniformly when given before ventilation of the premature lamb. They found that the use of high-frequency oscillatory ventilation improved the uniformity of distribution of radio-labeled surfactant after rescue treatment after a period of CV, based on greater aeration, which they demonstrated by semiquantitative morphometric examination of the lungs. This study did not include measurements of Crs to corroborate the improvement in distribution of surfactant.
We have reported preliminary observations of the distribution of surfactant mixed with india ink and Crs in preterm rabbit with and without HFV (5). We chose a period of 15 min of HFV as an adjunct to surfactant administration that would hypothetically improve the distribution of surfactant. We administered a low dose of surfactant to emphasize nonuniform distribution in its physiologic effect. In contrast to the studies in the lambs, we DISTRIBUTION O F SURFACTANT AND LUNG COMPLIANCE 27 1 found no difference in the distribution of india ink between rabbit pups treated at birth or after 15 rnin of ventilation ("rescue"). The Crs was significantly lower in those treated with HFV than in those treated with CV. The Crs of all animals significantly increased during 30 rnin of CV subsequent to HFV or rescue, which suggested that CV helped to distribute the surfactant. These observations led us to formulate the hypotheses of the present study: The distribution of surfactant is more uniform and the Crs greater in rabbit pups 1 ) if surfactant is given at birth rather than after CV, 2) if surfactant treatment at birth or after CV is followed by 15 rnin of HFV, and 3 ) if the treatment (surfactant and ventilation) regimes in (2) are followed by 30 min of CV.
MATERIALS AND METHODS
Studies were performed on a protocol approved by the University of California, San Diego Animal Resources Committee (no. 258-7) in accordance with guidelines of the American Physiological Society. The protocol is diagrammed in Figure 1 . Rabbit pups were randomized into three groups: those treated at birth, those rescued after 15 rnin of CV, and controls treated identically with CV or HFV but not with surfactant. Control pups were ventilated either with CV or HFV. We chose two forms of ventilation that are similar to those used in the human newborn with severe RDS. Conventional ventilation was delivered by a Baby-Bird ventilator (Bird Corp., Palm Springs, CA) at 30 breathslmin, PIP of 25 cm H20, PEEP of 0 cm H20, and inspiratory time 0.5 s (5). We did not use PEEP because it is associated with a high incidence of pneumothorax in these animals.
HFV settings were similar to those used for premature infants with RDS (6) but without positive end-expiratory pressure. HFV was delivered by an Infant Star ventilator (Infrasonics, San Diego, CA) with a frequency of 15 Hz, an amplitude of 30 cm H20, and a backup ventilator rate of 10 breathslmin, PIP of 25 cm H20, and PEEP of 0 cm H20. Mean airway pressures were 8.5 and 8.8 cm H 2 0 for CV and HFV, respectively. The first two groups were treated with surfactant either at birth or after 15 rnin of CV (rescue). Half of each group was then treated with 15 min of either CV or HFV. Pups were then given three breaths by CV for measurement of Crs. Half of each of the four groups were then removed from the plethysmograph for distribution studies (nine to 12 pups), and half were ventilated with CV for an additional 30 min before distribution studies (1 1-12 pups). Fig. 1 . Experimental protocol. Rabbit pups were randomized to receive surfactant at birth or after 15 rnin of CV, to rescue or to control groups. Surfactant administration was followed by 15 min of either CV or HFV. Compliance measurements were performed 15, 25, 35, and 45 rnin after surfactant administration while pups received CV. Eighty-nine pups were treated with radiolabeled surfactant for distribution studies and ventilated with either CV or HFV. They were killed immediately after CV or HFV or after an additional 30 min of CV. Numbers in parentheses indicate number of pups used for distribution studies.
Measurements of Crs were made immediately before rescue or at 15, 25, 35, and 45 min after surfactant administration.
Surfactant preparation. Natural rabbit surfactant was obtained from pooled lung lavages of anesthetized female adult rabbits using four to five repetitive saline airway lavages of 20 mL/kg each. Lavage fluid was centrifuged at 300 x g for 7 min to remove cellular debris. The supernatant was filtered through a 20-pm nylon mesh and centrifuged at 10 000 x g for 90 min. This pellet was resuspended in saline and layered over buffered 0.27 M sucrose that was layered over 0.55 M sucrose. After centrifugation at 27 000 x g for 60 min, the interphase was removed and was resuspended in 250 mL H20, then centrifuged at 10 000 x g for 120 min. This pellet was resuspended in water, and an aliquot was removed for phospholipid and protein determinations. The remainder was lyophilized at <I00 pm Hg vacuum for 48 h. The lyophilized powder was resuspended to a concentration of 20 mg phospholipid/mL, 150 mM NaCl, and 1.5 mM CaC12. Rabbit surfactant was radiolabeled by mixing the unlabeled surfactant with a suspension of liposomes made with [3H]choline-labeled DPPC (New England Nuclear, Boston, MA). The adequacy of the association of the [3H]DPPC with the natural surfactant aggregates was demonstrated by the comigration of [3H]DPPC and natural surfactant during sucrose gradient ultracentrifugation (7). The final sp act of the preparation was 0.3 pCi/mg phospholipid. The surface tension of the rabbit surfactant was tested using the pulsating bubble technique (Pulsating Bubble Surfactometer; Electronetic Corporation, Amherst, NY) (8) . The exogenous surfactant was tested for surface activity at a concentration of 10 mg/mL based upon phospholipid content, protein content 5.1 + 1.1 % by weight and in 150 mM NaCl and 1.5 mM CaC12. The time from initial bubble formation until the equilibrium surface tension (24.5 + 0.2 mN.M-') was achieved was 2.6 + 1.0 s (mean + SD, n = 8). After 5 min of pulsation at 20 pulses/min at 37"C, the minimum values of surface tension were 2.0 k 1.2 mN. m-', and the maximum values were 29.8 + 2.4 mN.m-' (mean + SD, n = 9). These values are similar to surface tension characteristics reported for human amniotic fluid surfactant (9) and bovine surfactant (10).
Physiologic preparation. We studied a total of 149 rabbit pups from 24 litters of time-mated rabbits. Preterm rabbits of 27.5 d gestation were chosen for their pure state of surfactant deficiency.
We induced anesthesia in the does (4.5 + 0.6 kg) with ketamine (35 mglkg, intramuscularly) and xylazine (5 mglkg, intramuscularly), and then maintained it with pentobarbital (50 mglkg i.v., as needed). We performed a tracheostomy and ventilated the does with oxygen using PIP of 16 cm H20, PEEP of 3 cm H20, and a ventilator rate of 20 breathslmin. An aliquot of amniotic fluid was aspirated for lung maturity studies before the delivery of the first pup of each litter. We exposed the pups through a uterotomy and gave them vecuronium (0.05 mg, intraperitoneally) while they were still in the amniotic sac to prevent spontaneous breathing. They were then delivered and weighed, and their sex was determined. We placed a tracheostomy with a 18-gauge blunt needle with its distal end placed in the midtrachea. The pups in the treatment groups were given surfactant at birth or after 15 min of conventional ventilation. For the pups treated at birth, we injected surfactant directly into the hub of the needle/tracheostomy that we noted was filled with fetal lung fluid. The surfactant was formulated into a volume of 0.1 mL (-60 mg phospholipid/kg) that was separated from 0.15 mL saline (flush) by 0.3 mL of air drawn into a 1-mL syringe. This was done to insure that the surfactant cleared the hub of the tracheostomy needle and reached the lungs. The initial instillation was followed by three injections of 0.3 mL of air to simulate three fixed-volume breaths to assist volume recruitment. The pups were placed immediately in the plethysmograph and mechanically ventilated. Pups that were subsequently rescued were given the same dose of surfactant and 0.15 mL saline followed by the same fixed-volume breaths while they remained in the plethysmograph.
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to about 1 mL/kg (Fig. 2, lower tracing) , as well as the tidal volumes of approximately 7 mL/kg of the back-up ventilatory breaths.
The lung profiles of the amniotic fluid from the fetuses had a mean lecithin/sphingomyelin ratio of 1.47 i-0.29, no detectable phosphatidylglycerol, and a phosphatidylinositol concentration of 9.4 _+ 2.5%. These values are consistent with other reports describing surfactant deficiency (1 6) in this animal model.
The time course of the mean Crs of each subgroup before surfactant and of those that were given 30 min of CV is shown in Figure 3 . The mean compliances of both control groups did not change throughout the experiment. The values from the two control groups were pooled to simplify the figure. The mean compliances of all rescue groups before treatment were not different from that of controls. The mean compliance of the rescue CV group at 15 min after surfactant was greater than that of the control groups and both prophylaxis groups ( p < 0.001) and was greater than that of the rescue HFV group ( p < 0.01).
The mean compliance of the rescue HFV group was significantly greater than that of either control group or groups treated at birth ( p < 0.05).
The mean compliances of all the rescue groups and those treated at birth continued to increase during the additional 30 rnin of CV. At 35 and 45 rnin after surfactant, the mean compliance of all treatment groups did not differ from each other.
There were no differences in the pulmonary resistances between the four treatment groups and controls, and there were no consistent changes in this parameter during the experiment.
The distributions of 3H-choline-labeled DPPC surfactant in lung pieces from the treatment groups immediately after 15 rnin of CV or HFV and after an additional 30 min of CV are shown in Figure 4 . The shaded area in each panel represents the mean + 1 SEM of the pooled data for the four treatment groups without (panel A ) and with (panel B) 30 rnin of additional CV. The distribution of surfactant was more uniform in the pups treated with an additional 30 rnin of CV than in those without CV. There was also less variability between pups receiving the 30 rnin of CV, inasmuch as the SEM was less than that for pups not receiving CV. Data from treatment subgroups are shown for comparison. The distribution appears more uniform in pups treated with CV than HFV, especially without 30 min of CV and if surfactant was given as a rescue.
To compare the distribution of the surfactant in the treatment groups, the number of lung pieces inside the central range of distribution intervals is shown in Table 1. In the pups not given additional CV (Table I) , distribution of surfactant was more uniform in pups treated with CV than in those treated with HFV ( X 2 = 52.2, p < 0.001). Within HFV groups, distribution of surfactant was more uniform in those treated at birth than in those rescued (X2 = 50.7, p < 0.001). There were no significant differences in distribution between CV groups treated at birth and rescue or between HFV and CV if surfactant was given at birth.
The additional 30 rnin of CV was associated with more uniform distribution of surfactant in pups treated as a rescue (Table   1 , CV, x2 = 37.8,p<0.001, HFV, x 2 = 55.7,p<0.001). The additional 30 rnin of CV did not improve the uniformity of distribution in pups treated at birth with either CV or HFV.
Only 6.9 x 10' counts (0.04% of the total for the lungs) were found in 0.5 mL of blood withdrawn at the conclusion of ventilation, whereas 97% of instilled counts were found in lung homogenate. The total counts in the lung blood would account for only about 0.02% of the total counts, assuming that the lung blood was in equilibrium with venous blood, the total blood volume was 85 mL/kg body weight, and the lung blood was 10% of the total blood volume. This suggests that the radiolabeled surfactant was contained in the airspaces and was not redistributed in a more uniform fashion because of uptake by the circulation.
The lungs of pups treated with surfactant had greater relative volumes of airspaces than those of control pups (Fig. 5) . The relative volume of airspaces ranged from 35 to 43% in the controls, with the right lower lobe consistently having higher values than other lobes, but not significantly so. The relative volumes of airspaces in the four treatment groups after 30 min of additional CV were significantly greater (p < 0.05), ranging from 56 to 72%. These values were similar in all of the treatment groups. No differences were noted between the lobes.
There were no significant differences in sex distribution between treatment and control groups. There were no differences based on sex in compliance, distribution, or morphometry between treatment and control groups.
DISCUSSION
In this study, we used physiologic measurements of lung function and morphologic measurements (on a macro-and microscopic scale) to assess the effect of CV and HFV, as they are applied to the premature infant with severe RDS (6), on the distribution of exogenous surfactant. Surfactant was given before mechanical ventilation or after an interval of CV or HFV. The measurement of Crs, a sensitive indicator of physiologic efficacy, was used to compare the effects of ventilation and the time of surfactant administration. Among the eight treatment groups, more uniform distribution of surfactant was associated with greater dynamic compliances.
We chose experimental conditions that would emphasize differences in lung function that we believed would reflect differences in the distribution of surfactant. We fulfilled two necessary experimental conditions: our rabbits were surfactant deficient, and the surfactant that we administered was efficacious if uniformly distributed. The phospholipid profile of the rabbits was consistent with surfactant immaturity, and the lung compliances in the rescue groups measured before surfactant administration were not significantly different from those of control animals. During the 30 rnin of CV after surfactant and CV or HFV treatment, the Crs increased regardless of the method of surfactant administration. The efficacy of the surfactant based on Crs was associated with the greater uniformity of distribution of radiolabeled surfactant and with the degree of aeration by microscopic examination. Our findings are different from previous observations. In preterm lambs, prophylactic treatment resulted in more uniform distribution than rescue treatment (3) and HFV produced improved aeration over CV (4). One explanation may be speciesrelated differences. Our rabbits were more mature (0.9 gestation) than the 125-132 d (0.8 gestation) pretenn lambs used in the previous studies. The preterm rabbit may be a more pure model of surfactant deficiency: rabbits may respond to surfactant treatment in lower doses than lambs, and the mode of ventilation after administration may thus be less critical.
Another explanation may be differences in surfactant efficacy. We used surfactant that contained all three surfactant-associated proteins, whereas previous investigators used a lipid extract that was deficient in SP-A. SP-A is known to improve the formation of stable surface-active films. The efficacy of lipid-extracted surfactant has also been shown to be improved by the addition of SP-A (17). The more uniform distribution that we observed may have been attributable to better spreading of natural surfactant, which makes it less dependent on the type of ventilation than previously used surfactants.
The application of HFV interfered with the distribution of surfactant on an anatomical scale of approximately 1/32 of the lungs. This corresponds roughly to the dimension of lung parenchyma ventilated by segmental bronchi. We speculate that HFV may have led to bubble formation in the large airways, which may have blocked the distribution of surfactant to all of the large airways, leading to the nonuniformity on this anatomical scale. Scarpelli et al. (1 8) have observed bubble formation in the distal conducting airways and saccular airways that were stable during lung deflation. He and others have speculated that these bubbles promote the inflation of the distal lung units, especially if the bubbles are stabilized by surfactant, as they would be with the application of exogenous surfactant. Thus, if large bubbles formed in the large central airways because of the application of HFV, they might have been of inappropriate size for breaking up in a uniform fashion as they were pushed into dichotomously dividing airways of progressively smaller size down to the saccular airways. This could explain why we observed nonuniformity of distribution at a macroscopic scale (radiolabel data), which was associated with significantly lower Crs, and not at microscopic examination (morphometry data).
The compliance values that we observed in our experiments
